2020 Scientific Retreat- Session 7

Session 7:  Recent Advances in Antibody-Drug Conjugates for the Treatment of Cancer 

1:20 PM – 2:30 PM 

Moderator:  
Marco Gottardis, PhD 
Janssen Research & Development, LLC 

Introduction 
Marco Gottardis, PhD 
Janssen Research & Development, LLC 

Antibody Drug Conjugates: From Early Stage Research to Clinically Approved Drugs 
Peter Senter, PhD 
Seattle Genetics 

Novel Approaches to Development of Antibody-Drug Conjugates for the Treatment of Cancer 
Yuuri Hashimoto, PhD 
Daiichi Sankyo Co., Ltd. 

PSMA Antibody Targeted Amanitin Conjugate (PSMA-ATAC): Introducing a Novel Mode of Action into Prostate Cancer Therap 
George Badescu, PhD 
Heidelberg Pharma AG 

Live Session Discussion 

Friday, October 23, 2020